Artice 3 of 3
We began this series with Carol — a 54-year-old woman in Ashland whose quiet cognitive changes were dismissed as normal aging. We showed you why they probably aren’t. We showed you that Alzheimer’s is, for women, a midlife disease that begins silently in the brain years before any test currently standard in our region would catch it. We showed you the menopause-brain connection — the estrogen story that the Women’s Health Initiative derailed for a generation, and that researchers like Dr. Lisa Mosconi are painstakingly restoring. And we showed you the landscape of Southern Oregon’s current resources: some real strengths, and some serious gaps.
In this final article, we get specific about what needs to change — and who needs to make it happen.
The Problem Is Not Knowledge Alone
One tempting response to everything in this series is educational: if doctors just knew more, things would change. Send them papers. Host a grand rounds. Update the guidelines.
This is necessary but not sufficient. The problem in Southern Oregon — as in most of rural America — is not only that providers lack knowledge. It is that the entire structure of how we deliver, fund, incentivize, and organize healthcare is misaligned with what the science now demands.
Consider: Dr. Mosconi’s research suggests that the optimal window for Alzheimer’s prevention in women is midlife — roughly 45 to 65. The interventions that work in this window are not medications so much as a comprehensive, sustained, personalized program: metabolic optimization, sleep attention, hormonal support where appropriate, lifestyle modification, biomarker tracking, and early detection of cognitive change.
That kind of care is time-intensive, relationship-dependent, and requires longitudinal follow-up over years. It is the opposite of the 15-minute primary care visit — the basic unit of care delivery in our region. A fee-for-service system that reimburses procedures and sick-visit encounters is structurally incapable of delivering what the science recommends. And so the science sits in academic journals while Carol gets told her brain is fine.
What The Evidence Says We Need — Locally
1. A Dedicated Alzheimer’s Prevention Clinic in the Rogue Valley
Weill Cornell Medicine has an Alzheimer’s Prevention Program. Cleveland Clinic has one. OHSU in Portland has a memory disorders clinic. The Rogue Valley — which serves over 600,000 people across nine counties — has no equivalent.
A regional Alzheimer’s prevention clinic would not need to replicate the research infrastructure of a major academic medical center. It would need, at minimum:
- A neurologist or geriatrician with expertise in early cognitive decline and women’s brain health
- Access to FDG-PET or equivalent brain metabolic imaging (currently unavailable locally for prevention purposes)
- Blood-based biomarker testing for amyloid and tau (now commercially available through companies like C2N)
- A dedicated nurse practitioner or PA trained in perimenopause and cognitive risk
- A health coach or nutritionist trained in brain-protective lifestyle interventions (the Bredesen model)
- Billing structures that allow for longer, prevention-focused visits — ideally through partnership with the Oregon Health Authority or federal value-based care models
Asante Rogue Regional is the natural home for such a clinic, given its regional reach, its existing neurology infrastructure, and its stated mission of comprehensive regional health leadership. The question is whether the institutional will and the funding model exist to build it.
2. Menopause-Literate Primary Care, At Scale
Dr. Gordon’s practice is extraordinary. But it serves a small number of patients, largely those with resources and proximity to Ashland. What Southern Oregon needs is not one exceptional practitioner — it needs a hundred competent ones.
This means systematic continuing medical education for primary care physicians and nurse practitioners in the region, specifically on:
- The current evidence on hormone therapy timing, formulation (transdermal estradiol, micronized progesterone), and brain health
- Cognitive risk screening tools appropriate for midlife women (beyond the MMSE or basic cognitive screens used for dementia)
- The neuroendocrinology of menopause — why it is a brain event, not just a reproductive one
- How to have nuanced, evidence-based conversations about APOE4 and genetic risk with female patients
Oregon Health & Science University, the Alzheimer’s Association Oregon chapter, and organizations like Reimagine Healthcare are well-positioned to develop and deliver this education. The Alzheimer’s Association already maintains a Jackson County presence and has staff dedicated to Southern Oregon (Christie Hill, Walk to End Alzheimer’s Manager for Southern Oregon). Engagement with that existing infrastructure is a logical starting point.
3. Payment Reform That Rewards Prevention
The single biggest structural barrier to the care women need is that the healthcare system does not pay for it.
A 15-minute visit to discuss hot flashes is reimbursable. A 90-minute initial visit to map a 52-year-old woman’s cognitive risk profile, review her family history, discuss biomarker testing options, create a prevention plan, and educate her about hormone therapy timing is not — at least not in any standard fee-for-service framework.
Oregon is actually better positioned than most states to address this. The state has invested significantly in value-based care models through the Oregon Health Plan’s Coordinated Care Organizations (CCOs). PacificSource, which serves many Southern Oregon patients, and AllCare Health, which serves Jackson and Josephine counties, both operate under CCO frameworks that theoretically allow for investment in prevention when it reduces downstream costs.
The economic argument is not subtle: a single Alzheimer’s patient in a memory care facility costs an average of nearly $5,000 per month in Jackson County. The lifetime cost of care for a person with Alzheimer’s is estimated at over $350,000. Every case prevented or delayed by even a few years represents enormous savings to families, to Medicaid, to the healthcare system. Prevention is not a nice-to-have. It is a financially rational investment that our current reimbursement system systematically fails to make.
Advocates in Southern Oregon can push CCOs, the Oregon Health Authority, and state legislators to develop specific codes and reimbursement pathways for comprehensive brain health prevention visits — modeled on, but distinct from, the existing wellness visit structure.
4. Research Participation and the CARE Initiative
In January 2025, Dr. Mosconi launched the CARE Initiative — Cutting Alzheimer’s Risk through Endocrinology — a $50 million global research program funded by the Wellcome Trust with an explicit goal of halving women’s Alzheimer’s risk by 2050. CARE is studying, among other things, how hormone therapy affects biological markers of Alzheimer’s in real time, what neuroendocrine factors across a woman’s entire reproductive history predict brain health outcomes, and how to build prevention models that work for diverse populations across the world.
Southern Oregon women cannot enroll in CARE directly from our region. But the existence of this initiative — and its expected results over the next three years — means that the evidence base for prevention-focused women’s brain health care is about to change substantially. Local practitioners and health systems would do well to track CARE’s progress and position themselves to implement its findings.
More immediately: participation in Oregon Health & Science University’s research programs, and advocacy for satellite research participation sites in Southern Oregon, would both serve the region’s residents and contribute to the national evidence base.
5. Community and Advocacy Infrastructure
None of the above happens without public pressure. Healthcare systems respond to organized demand. Legislative priorities respond to constituent voices. Insurance companies respond to actuarial evidence and regulatory pressure.
The Alzheimer’s Association Oregon & SW Washington Chapter has a Jackson County presence and staff dedicated to the Southern Oregon Walk to End Alzheimer’s and community education. Their 24/7 helpline (800-272-3900) and local programming are underutilized by most of the region’s residents.
There is real opportunity for Reimagine Healthcare, the Alzheimer’s Association, Asante’s community benefit programs, and local women’s health advocates to build a coordinated Southern Oregon Brain Health Coalition — one that specifically centers women’s risk, advocates for structural change, and holds local health systems accountable to prevention science.
A Letter to the Practitioners of Southern Oregon
This series is written for the general public, but we want to speak directly, briefly, to the physicians, nurse practitioners, and physician assistants of the Rogue Valley.
You are not the villains of this story. You were trained in a system that had the Women’s Health Initiative as its dominant text on hormones, that had no tools for pre-symptomatic Alzheimer’s prevention, that was not designed for the 90-minute prevention conversation. You are doing the best you can in a system with structural problems that precede your practice.
But the science has moved. The tools exist — blood-based biomarkers for amyloid and tau, validated cognitive screening tools for midlife populations, a new understanding of hormone therapy timing and formulation — that were not available even five years ago. The women in your waiting rooms who mention memory problems and are told it is probably stress or normal aging deserve better than that answer. Not because you are negligent, but because the answer is no longer supported by the evidence.
We are asking you to engage with this science, to reach out to colleagues who are ahead of the curve (Dr. Gordon at Northwest Wellness is a remarkable local resource even for referral purposes), and to advocate within your own institutions for the structures — clinic models, CME, reimbursement reform — that would let you practice the prevention medicine the evidence supports.
What Happens If We Don’t Change
Let us be direct about the stakes.
More than 79,000 Oregonians are currently living with Alzheimer’s. That number is projected to grow substantially over the next two decades as the population ages. In Medford alone, the percentage of senior deaths attributable to Alzheimer’s already exceeds the national average. The cost in dollars is enormous. The cost in human suffering — in the slow loss of identity, memory, and connection that Dr. Mosconi describes as “heartbreaking” — is incalculable.
The majority of those people are women. And the majority of the burden of their care falls on other women — unpaid family caregivers, daughters and daughters-in-law and wives, who restructure their own lives and careers and health to manage a disease that the healthcare system largely failed to prevent.
That is not inevitable. It is a policy choice, dressed in the language of inevitability.
What Happens If We Do
Dr. Mosconi’s CARE Initiative estimates that if research and intervention go according to plan, it may be possible to prevent 55 million new Alzheimer’s cases among women globally by 2050.
That is a global number. But the logic applies here. Every woman in Southern Oregon who gets a timely, informed conversation about menopause and brain health, who accesses hormone therapy at the right time, who gets her cognitive trajectory tracked in midlife rather than only at crisis, who understands her APOE4 status and acts on it — every one of those women represents a potential case of Alzheimer’s delayed, diminished, or prevented.
Carol is 54. She has time. The brain, as Dr. Mosconi emphasizes, is an extraordinarily resilient organ. The preclinical phase is long precisely because the brain fights hard to maintain itself. Carol’s brain is still fighting. What she needs — what all the Carols of Southern Oregon need — is a healthcare system that fights alongside it.
That is what reimagining healthcare looks like.
Resources and Next Steps
Alzheimer’s Association — Oregon & SW Washington Chapter
24/7 Helpline: 800-272-3900 | www.alz.org/orswwa
Northwest Wellness Center / Northwest Memory Care — Ashland, OR
Dr. Deborah Gordon’s integrative cognitive health practice
(541) 482-8333 | northwestwellness.net
Asante Neurology — Medford and Grants Pass
www.asante.org/services/neuroscience-and-stroke
Southern Oregon Gynecology (SOGYN) — Medford
Hormone consultations, menopause care | www.sogyn.com
The CARE Initiative — Weill Cornell Medicine
Cutting Alzheimer’s Risk through Endocrinology | wellcomeleap.org
Recommended Reading:
- The Menopause Brain by Dr. Lisa Mosconi (2024)
- The End of Alzheimer’s by Dr. Dale Bredesen
- The XX Brain by Dr. Lisa Mosconi (2020)
This series was produced by Reimagine Healthcare (wp.reimagine-healthcare.org/) for educational purposes. It is based on research published in peer-reviewed journals and the publicly available work of Dr. Lisa Mosconi and colleagues. It is not intended as medical advice. Please consult a qualified healthcare provider for personal medical guidance.